Financial toxicity and financial navigation
Cancer treatment can bankrupt patients even with insurance. Financial navigation programmes screen for money problems and connect patients to assistance, insurance optimisation and legal help, and trials show they reduce distress and debt.
'Financial toxicity' (Zafar 2013) describes the material, psychological and behavioural harm of cancer costs: ~40% of US patients deplete savings within two years (Gilligan 2018) and cancer patients are 2.65 times more likely to declare bankruptcy, which itself predicts mortality (Ramsey 2016). Drivers: high drug prices, cost-sharing, lost income, travel. Measurement: COST-FACIT. Interventions: proactive screening, financial navigators/counsellors (Lentz, Banegas), pharmaceutical assistance programmes, medication cost conversations, and policy (Inflation Reduction Act cap on Part D out-of-pocket costs from 2025; Medicaid expansion). Randomised and pragmatic trials (CAFÉ, 2024) show reduced financial distress and increased assistance uptake. Globally, catastrophic expenditure affects most cancer households in LMICs (ACTION study, Southeast Asia).
How it works
Treat cost as a side effect: screen routinely, quantify with validated tools, and assign trained staff to reduce out-of-pocket exposure through benefits, assistance programmes and treatment choices with equal efficacy and lower cost.
- Trials show reduced distress and recovered funds far exceeding programme cost
- Aligns with value-based care metrics
- Highlights price as a modifiable harm
- Does not address root cause (drug and service prices)
- Programmes concentrated in large centres
- LMIC household costs are largely unaddressed
Latest papers
topQuery for this technology: (TITLE:"Financial toxicity and financial navigation" OR ABSTRACT:"Financial toxicity and financial navigation") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Financial toxicity and financial navigation, not a curated reading list.
Pages like this
not linked directly; found by shared links- TechnologyOncology nursing and nurse-led care
Shares Telehealth and hospital-at-home in oncology, Cancer health disparities and equity and the tags gap-fill, supportive.
- ProductSodium thiosulfate (otoprotectant)
Shares Survivorship care and late-effects surveillance and the tags gap-fill, supportive.
- TechnologyElectronic patient-reported outcome (ePRO) symptom monitoring
Shares Telehealth and hospital-at-home in oncology and the tags gap-fill, supportive.
- TechnologyPsycho-oncology and distress screening
Shares Survivorship care and late-effects surveillance and the tags gap-fill, supportive.
- TechnologyBone-modifying agents (bisphosphonates, denosumab)
Shares Survivorship care and late-effects surveillance and the tags gap-fill, supportive.
- TechnologyEarly integrated palliative care
Shares Telehealth and hospital-at-home in oncology and the tags gap-fill, supportive.
- TermOncology workforce
Shares Telehealth and hospital-at-home in oncology, Cancer health disparities and equity and the tag gap-fill.
- TechnologyAntiemetics for chemotherapy-induced nausea and vomiting
Shares the tags gap-fill, supportive.